Lv7
5005 积分 2022-10-25 加入
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
22天前
已完结
Efficacy of the Bispecific Anti-BAFF/IL-21 Antibody CZ105 Bis2 in Models of Systemic Lupus Erythematosus
28天前
已完结
Developability-by-design for bispecific antibodies in discovery: combining computational prediction and early screening for candidate selection
28天前
已完结
CHO endogenous weak promoters facilitating the development of high-yield cell lines
1个月前
已完结
Synergistic viral inactivation platform: Rapid enveloped virus inactivation at mildly acidic pH using low non-ionic detergent in Protein A eluates
1个月前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
Beyond immune checkpoint blockade: T cell engagers and antibody-drug conjugates in cancer and autoimmune disease
1个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
2个月前
已完结
Engineering bispecific antibodies for brain delivery of biotherapeutics in multiple species
2个月前
已完结
Engineering of tandem bispecific IL-7 receptor agonist antibody promoting selective T cell expansion
2个月前
已完结
皖公网安备34019202002308
